News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Proneuron Biotechnologies, Inc. (US Branch) Announces Milestone Patent For Copolymer-1 -- Cop-1; Patent Expands Use Of Cop-1, Previously Approved For The Treatment Of MS


10/19/2005 5:12:44 PM

LOS ANGELES--(BUSINESS WIRE)--Feb. 15, 2005--Proneuron Biotechnologies, www.proneuron.com, announced today the granting of U.S. Patent No. 6,844,314 for the use of Copolymer-1 (Cop -1) for protection from neuronal degeneration. The patent was granted to Proneuron Scientific Founder Professor Michal Schwartz of the Weizmann Institute of Science. The patent, exclusively licensed to Proneuron, is owned by Yeda Research and Development Company Ltd., the commercial arm of the Weizmann Institute of Science.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES